Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
1994-06-17
2008-08-12
Mosher, Mary E (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C530S350000
Reexamination Certificate
active
07410646
ABSTRACT:
Immunologically active polypeptides with no or reduced toxicity useful for the preparation of an antipertussis vaccine. Method for the preparation of said polypeptides which comprises, cultivating a microorganism transformed with a hybrid plasmid including the gene/s which codes for at least one of said polypeptides in a suitable medium and recovering the desired polypeptide from the cells or from the culture medium.
REFERENCES:
patent: 5085862 (1992-02-01), Klein et al.
patent: 5773600 (1998-06-01), Burnette
Pizza, M. et al. 1989, Mutants of pertussis toxin suitable for vaccine development. Science. 246: 497-500.
Webster's II New Riverside University Dictionary Riverside Publishing Co. (1988).
Kumar, V. et. al. Proc. Natl. Acad. Sci. 87: 1337-41 (1990).
Bowie, J.U. etal. Science 247: 1306-1310 (1990).
Nicosia, A. et al. Jul. 1986. “Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication.” Proceedings of the National Academy of Sciences USA, vol. 83, p. 4631-4635.
Locht, C. et al. Jun. 1986. “Pertussis toxin gene: nucleotide sequence and genetic organization.” Science, vol. 232, p. 1258-1264.
Locht, C. et al. Nov. 1987. “Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized byEscherichia coli.” Infection and Immunity, vol. 55, p. 2546-2553.
Rappuoli, R. et al. Nov. 1986. “A recombinant DNA approach to the pertussis vaccine.” Bacterial Vaccines and Local Immunity—Ann. Sclavo, 1986, No. 1-2, p. 183-189.
Rappuoli. R. et al. 1987. “Pertussis toxin.” Chimicaoggi—maggio 1987, p. 46-48.
Pizza, M. et al. Oct. 1988. “Subunits S1 of pertussis toxin: Mapping of the regions essential for ADP-ribosyltransferase activity.” Proceedings of the National Academy of Sciences USA, vol. 85, p. 7521-7525.
Stibitz, S. et al. 1986. “The construction of a cloning vector designed for gene replacement inBordetella pertussis.” Gene, vol. 50, p. 133-140.
Black, W.J. et al. Oct. 1987. “Construction and characterization ofBordetella pertussistoxin mutants.” Infection and Immunity, vol. 55, p. 2465-2470.
Black, W.J. et al. Nov. 1986. “Non-toxigenic mutants ofBordetella pertussis.” Bacterial Vaccines and Local immunity—Ann. Sclavo, 1986, No. 1-2, p. 175-182.
Bartley, T.D. et al. Proceedings of the National Academy of Sciences USA, vol. 86, p. 8353-8357, Nov. 1989.
Bartoloni Antonella
Pizza Mariagrazia
Rappuoli Rino
Mosher Mary E
Novartis Vaccines and Diagnostics S.R.L.
Woodcock & Washburn LLP
LandOfFree
Immunologically active polypeptides with altered toxicity... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunologically active polypeptides with altered toxicity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunologically active polypeptides with altered toxicity... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4018964